首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer and metastasis reviews

缩写:CANCER METAST REV

ISSN:0167-7659

e-ISSN:1573-7233

IF/分区:8.7/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1115
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Sima Singh,Ada Raucci,Alessandra Glovi et al. Sima Singh et al.
Cancer disparities in low- and middle-income countries (LMICs) persist because of socioeconomic inequalities and limited access to screening infrastructure, which requires equitable diagnostic solutions. As researchers, we need to develop i...
Hongxing Zhang,Yiyue Ding,Lihui Gu et al. Hongxing Zhang et al.
Tumor recurrence often occurs years after initial treatment, driven by dormant tumor cells that evade detection and therapy. These quiescent cells can persist in primary or metastatic niches and later reawaken under favorable microenvironme...
Lian Liu,Guangyu Yao,Junhao Yang et al. Lian Liu et al.
The objective of this study is to compare the pathological complete response (pCR) and survival rates of different neoadjuvant chemoradiotherapy modalities (NACRT) for locally advanced rectal cancer, which is defined as rectal cancer with T...
Teng Zhou,Yuxin Yan,Mingxi Lin et al. Teng Zhou et al.
BrMs represent a significant clinical challenge due to its high incidence, complex biology, and poor prognosis. Astrocytes, the predominant glial cells in the central nervous system, are increasingly recognized for their central role in sha...
Sergei Kusmartsev Sergei Kusmartsev
The tumor metastatic dissemination and colonization is a highly complex, multi-step process that requires cooperation between cancer and host cells. Among these, cells of myeloid lineage mobilized from the bone marrow are crucial in facilit...
Mark Samuels,Simoni Besta,Andrea Lauer Betrán et al. Mark Samuels et al.
The emergence of CRISPR-Cas9 technology has transformed functional genomics, offering unmatched opportunities to dissect and understand biological pathways and identify novel therapeutic targets in cancer. Breast cancer is a complex, hetero...
Jinah Kim,Hye Sung Kim,Myungwoo Nam et al. Jinah Kim et al.
The landscape of cancer treatment has shifted from histology-specific to tissue-agnostic approaches, targeting molecular alterations regardless of tumor origin. Currently, six pan-cancer biomarkers-NTRK, BRAF V600E, RET, HER2-positive, MSI-...
Yamin Deng,Chen Wu,Jintong Na et al. Yamin Deng et al.
During the last three decades, there has been substantial advancement in comprehending the chemical attributes and roles of natural killer (NK) cells, resulting in a growing interest in these cells. Simultaneously, the swift advancement of ...
Bassel Alsaed,Nina Bobik,Hanna Laitinen et al. Bassel Alsaed et al.
The two most common and mutually exclusive driver mutations in non-small cell lung cancer affect EGFR and KRAS oncogenes. While EGFR mutations typically arise in non-smokers and are correlated with non-inflamed tumor microenvironment, KRAS ...
Kishore Banik,Thomas J Hayman Kishore Banik
Genomic instability is a hallmark of cancer and is associated with tumor progression and therapeutic resistance. Centrioles and centrosomes are a critical determinant of genomic stability. Polo-like kinase 4 (PLK4) is a serine-threonine kin...